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Abstract
Introduction To identify risk factors for early (< three days)
intensive care unit (ICU) admission of patients hospitalised with
community-acquired pneumonia (CAP) and not requiring
immediate ICU admission, and to stratify the risk of ICU
admission on days 1 to 3.
Methods Using the original data from four North American and
European prospective multicentre cohort studies of patients
with CAP, we derived and validated a prediction rule for ICU
admission on days 1 to 3 of emergency department (ED)
presentation, for patients presenting with no obvious reason for
immediate ICU admission (not requiring immediate respiratory
or circulatory support).
Results A total of 6560 patients were included (4593 and 1967
in the derivation and validation cohort, respectively), 303 (4.6%)
of whom were admitted to an ICU on days 1 to 3. The Risk of
Early Admission to ICU index (REA-ICU index) comprised 11
criteria independently associated with ICU admission: male
gender, age younger than 80 years, comorbid conditions,
respiratory rate of 30 breaths/minute or higher, heart rate of 125
beats/minute or higher, multilobar infiltrate or pleural effusion,
white blood cell count less than 3 or 20 G/L or above,
hypoxaemia (oxygen saturation < 90% or arterial partial
pressure of oxygen (PaO2) < 60 mmHg), blood urea nitrogen of
11 mmol/L or higher, pH less than 7.35 and sodium less than
130 mEq/L. The REA-ICU index stratified patients into four risk
classes with a risk of ICU admission on days 1 to 3 ranging from
0.7 to 31%. The area under the curve was 0.81 (95%
confidence interval (CI) = 0.78 to 0.83) in the overall population.
Conclusions The REA-ICU index accurately stratifies the risk of
ICU admission on days 1 to 3 for patients presenting to the ED
with CAP and no obvious indication for immediate ICU
admission and therefore may assist orientation decisions.
ATS: American Thoracic Society; CAP: community-acquired pneumonia; CI: confidence interval; ED: emergency department; EDCAP: Emergency 
Department Community-Acquired Pneumonia; ICU: intensive care unit; IRVS: intensive respiratory or vasopressor support; OR: odds ratio; PORT: 
Patient Outcomes Research Team; PSI: Pneumonia Severity Index; REA-ICU: risk of early admission to ICU; ROC: receiver operating characteristics; 
SCAP: severe community-acquired pneumonia.Critical Care    Vol 13 No 2    Renaud et al.
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Introduction
Approximately 10% of patients hospitalised for community-
acquired pneumonia (CAP) are admitted to an intensive care
unit (ICU), and these patients account for about 10% of all
medical admissions to ICUs [1,2]. Although some patients
with CAP have an obvious reason for ICU admission on the
day of presentation to the emergency department (ED), a sub-
stantial proportion of others will develop organ failure within a
few days [3]. Transfer to the ICU for delayed respiratory failure
or delayed onset of septic shock is associated with increased
mortality [4]. Hence, a major challenge in the management of
CAP is to identify patients at risk for rapidly developing
adverse medical outcomes among those presenting to the ED
with no obvious reason for immediate ICU admission.
Since the publication of the American Thoracic Society (ATS)
guidelines in 1993, several prediction rules have been derived
to identify ED patients with severe CAP, defined by adverse
outcomes (including ICU admission, shock requiring vaso-
pressors, acute respiratory failure requiring mechanical venti-
lation or death). Most of these prediction rules were derived in
populations including patients presenting with an obvious rea-
son for immediate ICU admission. However, a prediction rule
is essentially relevant to help management decisions for
patients not requiring immediate respiratory or circulatory sup-
port at presentation to the ED [5]. Additionally, previous rules
were designed to predict endpoints occurring within 30 days
of ED presentation, which may be an excessively remote per-
spective, when considering both the viewpoint of the ED and
ICU physicians' orientation decisions, and the potential relat-
edness of a late ICU transfer to physiological alterations
caused by pneumonia itself.
Therefore, our goals were to identify risk factors for ICU admis-
sion within three days of hospital stay for patients initially pre-
senting without respiratory failure or shock, and to derive and
validate a prediction rule to stratify the risk of ICU admission
on days 1 to 3.
Materials and methods
Study design
This study was based on data obtained from four prospective,
multicentre studies in adults with pneumonia. Two were from
North America, the Pneumonia Patient Outcomes Research
Team (PORT) cohort study and the Emergency Department
Community-Acquired Pneumonia (EDCAP) trial, and the two
other cohorts were from Europe (Pneumocom-1 and Pneumo-
com-2). The methods used for the Pneumonia PORT, EDCAP
and Pneumocom studies have been reported previously [6-9].
With the exception of the EDCAP cluster randomised trial, all
studies were observational. The study protocols were
approved by the institutional review boards of the participating
institutions. We received permission to use the data from the
four original multicentre studies and the need for informed
consent for the specific purpose of this study was waived.
Patients
All studies enrolled consenting adults with pneumonia. Nurs-
ing home residents with health care-associated pneumonia
were not eligible for the current analysis [10]. Additional exclu-
sion criteria (discharge within 7 to 10 days of presentation,
positive HIV antibody titre, immunosuppression, history of
cystic fibrosis, ventilation via a tracheostomy or chronic use of
mechanical ventilation) varied across the four original studies
(Additional data file 1). Patients presenting with acute respira-
tory failure requiring mechanical ventilation (invasive or nonin-
vasive mechanical ventilation) or shock (systolic arterial
pressure below 90 mmHg and requiring vasopressors) who
were transferred to the ICU on the same day of ED presenta-
tion were considered to have an obvious indication for imme-
diate ICU admission [11] and were excluded from the present
analysis. For the purposes of this study, 70% of the patients
were randomly assigned to a derivation cohort and 30% to an
internal validation cohort.
Baseline data collection
All four studies used physician interviews and standardised
reviews of medical records to collect baseline demographic
variables, comorbid illnesses, physical examination findings,
laboratory test results and radiographic findings. According to
previously published algorithms, prediction rules were derived
from each patient's baseline data [6,12,13]. In accordance
with methods used in these previous studies, missing varia-
bles were assumed to be normal [14,15].
Outcome measures
The primary outcome measure was the occurrence of ICU
admission on days 1 to 3 of ED presentation (Figure 1). The
secondary outcome was 28-day all-cause mortality.
Statistical analyses
Baseline and follow-up characteristics were reported as mean
and standard deviation or median and interquartile range for
continuous variables, and as percentages for discrete varia-
bles. We compared patient baseline characteristics according
to ICU admission on days 1 to 3, using the two-tailed t tests or
Wilcoxon tests for continuous variables, and chi-squared tests
or the Fisher's exact test for discrete variables.
We first developed a parsimonious logistic regression model
by removing variables from the full main effects model using a
backward approach with a cut-off value of P = 0.10. The vari-
ables introduced in the model included demographic charac-
teristics, comorbid conditions and physical, radiographic and
laboratory findings. Subsequently, we transformed the regres-
sion coefficients of the variables in the final model to an integer
value for each variable according to its contribution to the risk
estimation. Finally, we derived a four risk class prediction rule
for predicting ICU admission on days 1 to 3, and estimated the
area under the receiver operating characteristics (ROC) curve
for predicting ICU admission on days 1 to 3. We also esti-Available online http://ccforum.com/content/13/2/R54
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mated the area under the ROC curve of our score within each
original cohort. All analyses were performed using Stata ver-
sion 8.0 (Stata Corporation, College Station, TX, USA).
Results
Patient characteristics
Overall, 6560 patients were retained in our analysis, including
4593 (70%) in the derivation and 1967 (30%) in the validation
cohort (Figure 1). The characteristics of the two cohorts are
compared in Tables 1 and 2.
Outcomes measures
During the 28-day follow-up, 378 patients were admitted to an
ICU (5.6% and 6.0%, respectively in the derivation and valida-
tion cohorts; Table 2). More than 80% of ICU admissions
occurred within three days of ED presentation. Conversely,
nearly 80% of the 262 deaths occurred after three days,
whereas about 20% (53) of the deaths occurred within three
days of presentation.
Factors associated with ICU admission on days 1 to 3
Baseline characteristics associated with ICU admission on 
days 1 to 3
Patients admitted to the ICU on days 1 to 3 were more likely
to be elderly men with comorbidities, and to have more vital
sign abnormalities (altered mental status, tachypnoea and
hypotension), radiographic or laboratory abnormalities (hypox-
aemia, hyponatraemia, acidosis, high blood urea nitrogen level,
and pleural effusion or multilobar infiltrates; Tables 3 and 4).
Independent risk factors
In multivariable analysis, we identified 11 independent predic-
tors of ICU admission on days 1 to 3, including male gender,
age under 80 years and at least one comorbid condition; all
Figure 1
Patient enrolment Patient enrolment. CAP = community-acquired pneumonia; EDCAP = Emergency Department Community-Acquired Pneumonia; ICU = intensive 
care unit; MV = mechanical ventilation.Critical Care    Vol 13 No 2    Renaud et al.
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other independent risk factors were physical or laboratory find-
ings (Table 5).
Risk of early admission to the ICU
The risk of early admission to the ICU (REA-ICU) score ranged
from 0 to 17 and was stratified into four risk classes (REA-ICU
index; Table 6). In the derivation cohort the rate of ICU admis-
sion on days 1 to 3 ranged from 1.1% for risk class I to 27.1%
for risk class IV and 28-day mortality ranged from 1.2 to
15.1%. Similar rates were observed in the validation cohort. In
risk class I, five patients (not admitted to ICU) died within three
days of ED presentation. The risk class I patients accounted
for 2510 of 4593 (54.6%) and 1099 of 1967 (55.9%)
patients, respectively, in the derivation and validation cohorts,
with 27 out of 2510 (1.1%) and 14 out of 1099 (1.3%) of
these patients admitted to the ICU, respectively. Among these
41 patients, 10 were classified as high-risk using the Pneumo-
nia Severity Index (PSI) and none subsequently died.
The area under the ROC curves for the REA-ICU score was
0.80 (95% confidence interval (CI) = 0.77 to 0.83) and 0.80
(95% CI = 0.76 to 0.84) in the derivation and validation
cohorts, respectively.
The risk of admission to the ICU on days 1 to 3 increased sig-
nificantly from risk class I to risk class IV within each of the four
original cohorts (P < 0.001 for each cohort). The area under
the ROC curve of the score for predicting admission to an ICU
on days 1 to 3 ranged from 0.76 (95% CI = 0.72 to 0.90) in
the EDCAP cohort to 0.82 (95% CI = 0.85 to 0.90) in the
Pneumocom-2 cohort.
The REA-ICU score yielded a higher area under the ROC
curve than the PSI (0.75, 95% CI = 0.73 to 0.78), CURB-65
(0.69, 95% CI = 0.66 to 0.72) and Espana Severe CAP
(SCAP) (0.74, 95% CI = 0.71 to 0.76) for predicting ICU
admission on days 1 to 3 for patients not requiring immediate
circulatory or ventilatory support (P < 0.001 for all pairwise
comparisons involving the REA-ICU score).
Discussion
In this study, we identified 11 baseline characteristics that
were independently associated with ICU admission on days 1
to 3 in a broad range of patients presenting with CAP and no
obvious reason for immediate ICU admission (i.e. not requiring
immediate respiratory or circulatory support). These character-
istics included male gender, age younger than 80 years,
Table 1
Patient demographic characteristics, comorbid conditions and baseline physical examination findings
Characteristics Derivation sample Validation sample P value
(n = 4593) (n = 1967)
Demographic factors
Male gender, n (%) 2428 (52.9) 1040 (52.9) 0.99
Age, mean (SD), years 60 (20) 60 (20) 0.48
Comorbid conditions, n (%)
Neoplastic disease 229 (5.0) 120 (6.1) 0.06
Liver disease 71 (1.5) 30 (1.5) 0.95
Congestive heart failure 542 (11.8) 235 (11.9) 0.87
Renal disease 243 (5.3) 112 (5.7) 0.51
Coronary artery disease 792 (17.2) 318 (16.2) 0.29
Chronic pulmonary disease 1153 (25.1) 474 (24.1) 0.39
Diabetes mellitus 672 (14.6) 284 (14.4) 0.84
Physical examination findings
Altered mental status, n (%) 275 (6.0) 120 (6.1) 0.96
Respiratory rate, median (IQR), per minute 22 (20 to 26) 22 (20 to 26) 0.72
Pulse, median (IQR), per minute 97 (84 to 112) 97 (84 to 110) 0.28
Systolic BP, median (IQR), mmHg 132 (118 to 150) 131 (118 to 150) 0.67
Temperature, median (IQR), °C 37.7 (36.8 to 38.5) 37.6 (36.8 to 38.5) 0.07
Oxygen saturation, median (IQR), % 94 (90 to 96) 94 (91 to 97) 0.07
Missing values were assumed to be normal for respiratory rate (n = 819; 12%), pulse (n = 356, 5%), systolic (n = 314, 5%), temperature (n = 
323, 5%) and comorbid conditions (< 2%). BP = blood pressure; ICU = intensive care unit; IQR = interquartile range.Available online http://ccforum.com/content/13/2/R54
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comorbid condition of 1 or higher, tachypnoea, tachycardia,
leukopenia or leukocytosis, multilobar infiltrates or pleural effu-
sion, hypoxaemia, acidosis, hyperuraemia and hyponatraemia.
From this set of variables, we derived a prediction rule, REA-
ICU score, that demonstrated a consistent discriminatory
power for predicting ICU admission occurring within three
days of ED presentation for patients with CAP not requiring
immediate ICU transfer.
The British Thoracic Society advocates using a set of only four
variables (CURB-65) and suggests considering ICU referral
when three or more criteria are present [13]. The ATS rule,
modified in 2001 [16], appears to have a slightly better pre-
dicting accuracy than the CURB-65 or the PSI; however, it still
results in a substantial proportion of patients misclassified with
regard to ICU admission [17]. Moreover, the two major criteria
of the ATS rule – requirements for mechanical ventilation and
the occurrence of shock – are obvious reasons for ICU admis-
sion. Espana and colleagues derived the SCAP prediction rule
that was shown to discriminate better than previous prediction
rules between ED patients with and without CAP-related
adverse medical outcomes, including 30-day mortality and
ICU referral [12]. Narrowing the criteria for severe CAP need-
ing ICU admission to the requirement for intensive respiratory
or vasopressor support (IRVS), Charles and colleagues
recently developed the SMART-COP, which demonstrated
interesting characteristics to predict IRVS requirement during
the whole hospital course of patients [18]. We took a different
perspective and focused on patients not presenting to the ED
with a need for IRVS, but subsequently transferred to the ICU
within the first three days of admission; thus, our index might
be especially useful for emergency physicians to assess the
potential risk of ICU requirement within the next few days
among those patients presenting with none of the ATS major
severity criteria. As a result, the REA-ICU performed signifi-
cantly better than existing prediction rules (PSI, CURB-65,
Table 2
Patient baseline laboratory and x-ray findings, Pneumonia Severity Index and clinical outcomes within 28 days
Characteristics Derivation sample Validation sample P value
(n = 4593) (n = 1967)
Laboratory and x-ray findings
Arterial pH, median (IQR) 7.45 (7.41 to 7.47) 7.44 (7.41 to 7.47) 0.59
Arterial partial pressure of oxygen, median (IQR), mmHg 63 (55 to 74) 64 (55 to 73) 0.62
BUN, median (IQR), mEq/L 6 (4 to 9) 6 (4 to 9) 0.81
Sodium, median (IQR), mEq/L 137 (134 to 139) 137 (134 to 139) 0.63
Glucose, median (IQR), % 7 (6 to 9) 7 (6 to 9) 0.97
Multilobar infiltrates 39 (35 to 42) 39 (36 to 42) 0.48
WBC, median (IQR), G/L 11.7 (8.5 to 15.8) 11.2 (8.1 to 15.3) 0.04
Multilobar infiltrates, n (%) 0.80
Pleural effusion, n (%) 503 (10.9) 206 (10.5) 0.57
Pneumonia Severity Index, n (%) 0.80
Class I 1259 (27.4) 538 (27.3)
Class II 1075 (23.4) 479 (24.3)
Class III 877 (19.1) 372 (18.9)
Class IV 1104 (24.0) 451 (22.9)
Class V 278 (6.0) 127 (6.5)
Outcomes
ICU admission ≤ 3 days, n (%) 201 (4.4) 102 (5.2) 0.15
3-day mortality, n (%) 41 (0.9) 12 (0.6) 0.24
28-day ICU admissions, n (%) 259 (5.6) 119 (6.0) 0.51
28-day mortality, n (%) 184 (4.0) 78 (4.0) 0.94
Missing values were assumed to be normal for arterial pH (n = 4247, 65%), arterial partial pressure of oxygen or oxygen saturation (n = 1029, 
15%), BUN (n = 1685, 26%), sodium (n = 1565, 24%), glucose (n = 1637, 25%), haematocrit (n = 1205, 18%), WBC (n = 1185, 18%). BP = 
blood pressure; BUN = blood urea nitrogen; ICU = intensive care unit; IQR = interquartile range; WBC = white blood cell.Critical Care    Vol 13 No 2    Renaud et al.
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Espana SCAP) in predicting ICU admission on days 1 to 3 of
ED presentation in these patients.
Indeed, the criteria for inclusion in our analysis have several
distinctive features from previous attempts at predicting CAP
severity. First, contrasting with previous prediction rules, we
focused on the more challenging subgroup of patients pre-
senting with moderately severe CAP and no requirement for
immediate ICU admission [11]; hence, we excluded patients
with obvious respiratory or haemodynamic failure at presenta-
tion. Indeed, including such clinically apparent features in a
prediction rule is likely to improve its operative characteristics,
but is of limited value in assisting physicians in triaging
patients [19,20].
Second, we focused on admission to ICU within three days of
ED presentation, instead of including all 28-day outcomes.
Pneumonia is the most common cause of severe sepsis, and
severe CAP should be seized in the overall context of sepsis
from pulmonary infection with organ dysfunction(s) potentially
requiring intensive care [5,21]. Indeed, most sepsis-related
organ failures in this setting occur early [3,22]. Accordingly,
our findings in a large sample of patients presenting with CAP
confirm that admission to ICU mostly occurred within the first
three days of ED presentation. In addition, late ICU admissions
may be associated with other factors than the severity of pneu-
monia itself (e.g. decompensated comorbidity or an intercur-
rent event), and not be influenced by its initial management
[23-25]. Moreover, the REA-ICU score was based on data
readily available at patient presentation to the ED and did not
include results from ED monitoring, which would be less rele-
vant to triaging patients in the ED setting [12,26]. Accordingly,
we could not include laboratory tests that were not evenly col-
lected across the four original studies (e.g. albuminaemia).
Table 3
Association of patient demographic characteristics, comorbid conditions and baseline physical examination findings with intensive 
care unit admission within three days of presentation
Characteristics Derivation cohort Validation cohort
Admission to ICU ≤ 3 days P value Admission to ICU ≤ 3 days P value*
No (4392) Yes (201) No (1865) Yes (102)
Demographic factors
Male gender, % 52.4 63.7 0.002 52.5 59.8 0.15
Age, mean (SD) years 59 (21) 67 (15) < 0.001 60 (21) 65 (16) 0.01
Comorbid conditions, %
Cancer 5.0 5.5 0.75 5.8 11.8 0.01
Cerebrovascular disease 6.8 8.9 0.15 6.9 6.5 0.87
Liver disease 1.5 20. 0.60 1.4 3.9 0.04
Congestive heart failure 11.2 25.9 < 0.001 11.4 21.6 0.002
Renal disease 4.9 14.4 < 0.001 5.4 10.8 0.02
Coronary artery disease 16.6 30.8 < 0.001 15.9 20.6 0.21
Chronic pulmonary disease 24.8 31.3 0.04 23.9 28.4 0.29
Diabetes mellitus 14.3 21.4 0.006 13.7 27.4 < 0.001
Physical examination findings, %
Altered mental status 5.5 15.9 < 0.001 5.7 12.7 0.004
Respiratory rate ≥ 30 breaths/minute 12.3 33.8 < 0.001 11.5 35.3 < 0.001
Systolic BP < 90 mmHg 1.5 5.0 < 0.001 1.2 2.0 0.48
Temperature < 35 or ≥ 40°C 5.6 9.4 0.02 5.8 12.7 0.005
Pulse ≥ 125 beats/minute 8.8 18.4 < 0.001 7.5 23.5 < 0.001
Oxygen saturation, < 90% 13.6 44.4 < 0.001 14.0 46.4 < 0.001
Admission to ICU ≤ 3 days refers to patients who were admitted to an ICU within 3 days of presentation at the emergency department. * P value 
refers to the variables associated with admission to ICU within 3 days of presentation.
BP = blood pressure; ICU = intensive care unit; SD = standard deviation.Available online http://ccforum.com/content/13/2/R54
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Third, we considered that adequate ICU admission should not
be restricted to patients requiring IRVS [19]. Indeed, ICU care
has been demonstrated to improve outcome in severely ill and
unstable patients, and these patients require intensive moni-
toring and may potentially need immediate intervention [27].
Therefore, given the characteristics of the REA-ICU (Addi-
tional data file 2), we suggest that intensive care physicians be
informed of those patients with the highest risk of three-day
ICU admission. This could be achieved by requesting the
advice of an intensivist for such patients, who would then help
decide on the most appropriate site of care for providing them
adequate management and close monitoring, possibly in the
ICU or an intermediate-care unit as deemed appropriate.
Fourth, despite substantial differences across the four original
cohorts in patient characteristics and outcomes (Tables 1 and
2) [6-9], the overall discriminatory power of the REA-ICU
score in predicting ICU admission on days 1 to 3 was quite
high across the four original cohorts, reflecting the robustness
of this score [28].
Several potential limitations of our study must be acknowl-
edged. First, there were slight methodological differences and
exclusion criteria across the four cohorts analysed. However,
the definitions used in EDCAP, Pneumocom-1 and Pneumo-
com-2 were all based on the Pneumonia PORT study. Sec-
ond, our findings do not take into account processes of care
or causative pathogens, which may have confounded the rela-
tion between risk class and patient outcomes. As these data
were not collected in a standardised manner across the four
studies, we could not adjust for these variables. Third, the
REA-ICU score includes 11 variables, which might limit its
applicability to clinical use. However, the 20-variable PSI has
been successfully implemented in various settings, including
routine practice [7,9,29-31]. Fourth, our findings are based
solely on hospital admission data and patient monitoring data
were not recorded during the initial hospital course, so we
Table 4
Association of patient laboratory and x-ray findings, and Pneumonia Severity Index with ICU admission within three days of 
presentation
Characteristics Derivation cohort Validation cohort
Admission to ICU
≤ 3 days
P value Admission to
ICU ≤ 3 days
P value*
No (4392) Yes (201) No (1865) Yes (102)
Laboratory and x-ray findings, %
Arterial pH < 7.35 2.3 10.9 < 0.001 2.6 19.6 < 0.001
BUN ≥ 10 mmol/L 13.0 37.8 < 0.001 12.9 30.4 < 0.001
Sodium < 130 mEq/L 3.9 11.7 < 0.001 3.0 13.0 < 0.001
Glucose ≥ 14 mmol/dL 4.8 9.9 0.001 5.1 10.9 0.02
Haematocrit < 30% 4.5 10.9 < 0.001 4.7 11.8 0.002
WBC < 3 or ≥ 20 G/L 9.1 18.9 < 0.001 8.4 18.6 < 0.001
PaO2 < 60 mmHg 21.9 54.7 < 0.001 18.9 56.9 < 0.001
Pleural effusion 10.4 21.9 < 0.001 10.1 17.6 0.01
Multilobar infiltrates 22.0 41.8 < 0.001 22.2 39.2 < 0.001
Pneumonia Severity Index, %
Class I 28.4 5.0 < 0.001 28.6 4.9 < 0.001
Class II 24.0 10.9 24.9 13.7
Class III 19.1 17.9 18.7 22.5
Class IV 23.0 46.8 22.2 35.3
Class V 5.4 19.4 5.5 23.5
Admission to ICU ≤ 3 days refers to patients who were admitted to an ICU within three days of presentation to the emergency department. * P 
value refers to the variables associated with admission to ICU within 3 days of presentation. BUN = blood urea nitrogen; ICU = intensive care unit; 
PaO2 = arterial partial pressure of oxygen; WBC = white blood cell.Critical Care    Vol 13 No 2    Renaud et al.
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could not analyse the adequacy of secondary ICU admission
(e.g. requirement for mechanical ventilation or vasopressor, or
other reason for ICU admission). Fifth, all laboratory tests were
performed at the discretion of the attending physicians and
missing values were assumed to be normal. This strategy is
widely used in the clinical application of prediction rules and
reflects the methods used in the original derivation and valida-
tion of the PSI [15]. Indeed, patients with less severe illness
were more likely to have missing values for laboratory findings.
Finally, prediction scores often perform better in their deriva-
tion and internal validation cohorts than in external validation
studies; therefore, external independent validation is required.
Conclusions
In summary, using a large database combining four prospec-
tive cohorts of patients with CAP, we derived and validated the
REA-ICU index to predict ICU referral within the first three
days of hospital admission in patients without overt circulatory
or respiratory failure at ED presentation. This index demon-
strates valuable characteristics for stratifying the risk of admis-
sion to ICU on hospital days 1 to 3. Using this combination of
Table 5
Adjusted coefficients and odd ratios for admission to ICU within three days of presentation and points assigned in the predictive 
model
Characteristics β
parameter
95% CI (β parameter) OR 95% CI (OR) Points
assigned
Male 0.39 (0.08 to 0.70) 1.47 (1.08 to 2.01) 1
Comorbid condition ≥ 1 0.45 (0.11 to 0.78) 1.57 (1.12 to 2.19) 1
Respiratory rate ≥ 30 breaths/minutes 0.53 (0.18 to 0.88) 1.70 (1.20 to 2.41) 1
White blood cell count < 3 or ≥ 20 G/L 0.54 (0.14 to 0.94) 1.71 (1.15 to 2.55) 1
Heart rate ≥ 125 beats/minute 0.55 (0.14 to 0.95) 1.73 (1.15 to 2.60) 1
Age < 80 years 0.57 (0.18 to 0.95) 1.76 (1.19 to 2.59) 1
Multilobar infiltrates or pleural effusion 0.79 (0.48 to 1.09) 2.19 (1.62 to 2.97) 2
Oxygen saturation< 90% or PaO2 < 60 mmHg 0.85 (0.53 to 1.17) 2.35 (1.71 to 3.23) 2
Arterial pH < 7.35 0.91 (0.38 to 1.44) 2.49 (1.47 to 4.22) 2
Blood urea nitrogen ≥ 11 mmol/L 0.94 (0.61 to 1.28) 2.56 (1.84 to 3.58) 2
Sodium < 130 mEq/L 1.06 (0.58 to 1.53) 2.88 (1.79 to 4.63) 3
CI = confidence Interval; OR = odds ratio; PaO2 = arterial partial pressure of oxygen.
Table 6
Population and outcomes stratification according to the risk of early ICU admission index (REA-ICU index) of patients with 
community acquired pneumonia
Derivation population Validation population
Risk class Score NI C U   ≤ 3 days,
% (95% CI)
Death ≤ 28 days,
% (95% CI)
nI C U   ≤ 3 days,
% (95% CI)
Death ≤ 28 days,
% (95% CI)
I ≤ 3 2510 1.1
(0.7 to 1.6)
1.2
(0.8 to 1.8)
1099 1.3
(0.7 to 2.1)
1.9
(1.2 to 2.9)
II 4 to 6 1498 5.5
(4.4 to 6.8)
6.0
(4.8 to 7.3)
633 7.1
(5.2 to 9.4)
4.4
(3.0 to 6.3)
III 7 to 8 419 11.0
(8.2 to 14.4)
9.1
(6.5 to 12.2)
164 12.2
(7.6 to 18.2)
7.9
(4.2 to 13.2)
IV ≥ 9 166 27.1
(20.5 to 34.5)
15.1
(10.0 to 21.4)
71 32.4
(21.7 to 44.5)
22.5
(13.5 to 34.0)
Total 4593 4.4
(6.0 to 7.4)
4.0
(3.4 to 4.6)
1967 5.2
(5.8 to 8.0)
4.0
(3.1 to 4.9)
ICU ≤ 3 days and death ≤ 28 days refer to patients who were admitted to an ICU within three days of presentation to the emergency department 
or who died within 28 days of presentation, respectively. Results are expressed as percentages of each outcome within each REA-ICU risk class. 
CI = confidence interval; ICU = intensive care unit.Available online http://ccforum.com/content/13/2/R54
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variables might help ED physicians to more accurately assess
the potential need for ICU admission in the challenging group
of high-risk patients presenting with no obvious reason for ICU
admission [5,32,33].
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